Human Organoids Market Size, Trends & Growth Report by 2034

Market Segmentation

Human Organoids Market, By Product (2022-2034)

Media & Supplements
Reagents
Organoid Models

Human Organoids Market, By Organ Type (2022-2034)

Stomach Models
Intestine Models
Liver Models
Pancreatic Models
Lung Models
Brain Models
Kidney Models
Other Products

Human Organoids Market, By Source (2022-2034)

Adult Stem Cells
Induced Pluripotent Stem Cells
Embryonic Stem Cells
Other Sources

Human Organoids Market, By Application (2022-2034)

Developmental Biology
Drug Toxicity & Efficacy Testing
Disease Pathology
Personalized Medicine
Regenerative Medicine

Human Organoids Market, By End Use (2022-2034)

Pharmaceutical & Biotechnology Companies
CROs & CDMOs
Academic & Research Institutes
Other End Use

Regional Human Organoids Market

North America
1. North America Human Organoids Market, By Product
  1. Media & Supplements
  2. Reagents
  3. Organoid Models
2. North America Human Organoids Market, By Organ Type
  1. Stomach Models
  2. Intestine Models
  3. Liver Models
  4. Pancreatic Models
  5. Lung Models
  6. Brain Models
  7. Kidney Models
  8. Other Products
3. North America Human Organoids Market, By Source
  1. Adult Stem Cells
  2. Induced Pluripotent Stem Cells
  3. Embryonic Stem Cells
  4. Other Sources
4. North America Human Organoids Market, By Application
  1. Developmental Biology
  2. Drug Toxicity & Efficacy Testing
  3. Disease Pathology
  4. Personalized Medicine
  5. Regenerative Medicine
5. North America Human Organoids Market, By End Use
  1. Pharmaceutical & Biotechnology Companies
  2. CROs & CDMOs
  3. Academic & Research Institutes
  4. Other End Use
6. U.S.
  1. U.S. Human Organoids Market, By Product
    1. Media & Supplements
    2. Reagents
    3. Organoid Models
  2. U.S. Human Organoids Market, By Organ Type
    1. Stomach Models
    2. Intestine Models
    3. Liver Models
    4. Pancreatic Models
    5. Lung Models
    6. Brain Models
    7. Kidney Models
    8. Other Products
  3. U.S. Human Organoids Market, By Source
    1. Adult Stem Cells
    2. Induced Pluripotent Stem Cells
    3. Embryonic Stem Cells
    4. Other Sources
  4. U.S. Human Organoids Market, By Application
    1. Developmental Biology
    2. Drug Toxicity & Efficacy Testing
    3. Disease Pathology
    4. Personalized Medicine
    5. Regenerative Medicine
  5. U.S. Human Organoids Market, By End Use
    1. Pharmaceutical & Biotechnology Companies
    2. CROs & CDMOs
    3. Academic & Research Institutes
    4. Other End Use
7. Canada
Europe
1. Europe Human Organoids Market, By Product
  1. Media & Supplements
  2. Reagents
  3. Organoid Models
2. Europe Human Organoids Market, By Organ Type
  1. Stomach Models
  2. Intestine Models
  3. Liver Models
  4. Pancreatic Models
  5. Lung Models
  6. Brain Models
  7. Kidney Models
  8. Other Products
3. Europe Human Organoids Market, By Source
  1. Adult Stem Cells
  2. Induced Pluripotent Stem Cells
  3. Embryonic Stem Cells
  4. Other Sources
4. Europe Human Organoids Market, By Application
  1. Developmental Biology
  2. Drug Toxicity & Efficacy Testing
  3. Disease Pathology
  4. Personalized Medicine
  5. Regenerative Medicine
5. Europe Human Organoids Market, By End Use
  1. Pharmaceutical & Biotechnology Companies
  2. CROs & CDMOs
  3. Academic & Research Institutes
  4. Other End Use
6. U.K.
  1. U.K. Human Organoids Market, By Product
    1. Media & Supplements
    2. Reagents
    3. Organoid Models
  2. U.K. Human Organoids Market, By Organ Type
    1. Stomach Models
    2. Intestine Models
    3. Liver Models
    4. Pancreatic Models
    5. Lung Models
    6. Brain Models
    7. Kidney Models
    8. Other Products
  3. U.K. Human Organoids Market, By Source
    1. Adult Stem Cells
    2. Induced Pluripotent Stem Cells
    3. Embryonic Stem Cells
    4. Other Sources
  4. U.K. Human Organoids Market, By Application
    1. Developmental Biology
    2. Drug Toxicity & Efficacy Testing
    3. Disease Pathology
    4. Personalized Medicine
    5. Regenerative Medicine
  5. U.K. Human Organoids Market, By End Use
    1. Pharmaceutical & Biotechnology Companies
    2. CROs & CDMOs
    3. Academic & Research Institutes
    4. Other End Use
7. Germany
8. France
9. Spain
10. Italy
11. Russia
12. Nordic
13. Benelux
14. Rest of Europe
APAC
1. APAC Human Organoids Market, By Product
  1. Media & Supplements
  2. Reagents
  3. Organoid Models
2. APAC Human Organoids Market, By Organ Type
  1. Stomach Models
  2. Intestine Models
  3. Liver Models
  4. Pancreatic Models
  5. Lung Models
  6. Brain Models
  7. Kidney Models
  8. Other Products
3. APAC Human Organoids Market, By Source
  1. Adult Stem Cells
  2. Induced Pluripotent Stem Cells
  3. Embryonic Stem Cells
  4. Other Sources
4. APAC Human Organoids Market, By Application
  1. Developmental Biology
  2. Drug Toxicity & Efficacy Testing
  3. Disease Pathology
  4. Personalized Medicine
  5. Regenerative Medicine
5. APAC Human Organoids Market, By End Use
  1. Pharmaceutical & Biotechnology Companies
  2. CROs & CDMOs
  3. Academic & Research Institutes
  4. Other End Use
6. China
  1. China Human Organoids Market, By Product
    1. Media & Supplements
    2. Reagents
    3. Organoid Models
  2. China Human Organoids Market, By Organ Type
    1. Stomach Models
    2. Intestine Models
    3. Liver Models
    4. Pancreatic Models
    5. Lung Models
    6. Brain Models
    7. Kidney Models
    8. Other Products
  3. China Human Organoids Market, By Source
    1. Adult Stem Cells
    2. Induced Pluripotent Stem Cells
    3. Embryonic Stem Cells
    4. Other Sources
  4. China Human Organoids Market, By Application
    1. Developmental Biology
    2. Drug Toxicity & Efficacy Testing
    3. Disease Pathology
    4. Personalized Medicine
    5. Regenerative Medicine
  5. China Human Organoids Market, By End Use
    1. Pharmaceutical & Biotechnology Companies
    2. CROs & CDMOs
    3. Academic & Research Institutes
    4. Other End Use
7. Korea
8. Japan
9. India
10. Australia
11. Taiwan
12. South East Asia
13. Rest of Asia-Pacific
Middle East and Africa
1. Middle East and Africa Human Organoids Market, By Product
  1. Media & Supplements
  2. Reagents
  3. Organoid Models
2. Middle East and Africa Human Organoids Market, By Organ Type
  1. Stomach Models
  2. Intestine Models
  3. Liver Models
  4. Pancreatic Models
  5. Lung Models
  6. Brain Models
  7. Kidney Models
  8. Other Products
3. Middle East and Africa Human Organoids Market, By Source
  1. Adult Stem Cells
  2. Induced Pluripotent Stem Cells
  3. Embryonic Stem Cells
  4. Other Sources
4. Middle East and Africa Human Organoids Market, By Application
  1. Developmental Biology
  2. Drug Toxicity & Efficacy Testing
  3. Disease Pathology
  4. Personalized Medicine
  5. Regenerative Medicine
5. Middle East and Africa Human Organoids Market, By End Use
  1. Pharmaceutical & Biotechnology Companies
  2. CROs & CDMOs
  3. Academic & Research Institutes
  4. Other End Use
6. UAE
  1. UAE Human Organoids Market, By Product
    1. Media & Supplements
    2. Reagents
    3. Organoid Models
  2. UAE Human Organoids Market, By Organ Type
    1. Stomach Models
    2. Intestine Models
    3. Liver Models
    4. Pancreatic Models
    5. Lung Models
    6. Brain Models
    7. Kidney Models
    8. Other Products
  3. UAE Human Organoids Market, By Source
    1. Adult Stem Cells
    2. Induced Pluripotent Stem Cells
    3. Embryonic Stem Cells
    4. Other Sources
  4. UAE Human Organoids Market, By Application
    1. Developmental Biology
    2. Drug Toxicity & Efficacy Testing
    3. Disease Pathology
    4. Personalized Medicine
    5. Regenerative Medicine
  5. UAE Human Organoids Market, By End Use
    1. Pharmaceutical & Biotechnology Companies
    2. CROs & CDMOs
    3. Academic & Research Institutes
    4. Other End Use
7. Turkey
8. Saudi Arabia
9. South Africa
10. Egypt
11. Nigeria
12. Rest of MEA
LATAM
1. LATAM Human Organoids Market, By Product
  1. Media & Supplements
  2. Reagents
  3. Organoid Models
2. LATAM Human Organoids Market, By Organ Type
  1. Stomach Models
  2. Intestine Models
  3. Liver Models
  4. Pancreatic Models
  5. Lung Models
  6. Brain Models
  7. Kidney Models
  8. Other Products
3. LATAM Human Organoids Market, By Source
  1. Adult Stem Cells
  2. Induced Pluripotent Stem Cells
  3. Embryonic Stem Cells
  4. Other Sources
4. LATAM Human Organoids Market, By Application
  1. Developmental Biology
  2. Drug Toxicity & Efficacy Testing
  3. Disease Pathology
  4. Personalized Medicine
  5. Regenerative Medicine
5. LATAM Human Organoids Market, By End Use
  1. Pharmaceutical & Biotechnology Companies
  2. CROs & CDMOs
  3. Academic & Research Institutes
  4. Other End Use
6. Brazil
  1. Brazil Human Organoids Market, By Product
    1. Media & Supplements
    2. Reagents
    3. Organoid Models
  2. Brazil Human Organoids Market, By Organ Type
    1. Stomach Models
    2. Intestine Models
    3. Liver Models
    4. Pancreatic Models
    5. Lung Models
    6. Brain Models
    7. Kidney Models
    8. Other Products
  3. Brazil Human Organoids Market, By Source
    1. Adult Stem Cells
    2. Induced Pluripotent Stem Cells
    3. Embryonic Stem Cells
    4. Other Sources
  4. Brazil Human Organoids Market, By Application
    1. Developmental Biology
    2. Drug Toxicity & Efficacy Testing
    3. Disease Pathology
    4. Personalized Medicine
    5. Regenerative Medicine
  5. Brazil Human Organoids Market, By End Use
    1. Pharmaceutical & Biotechnology Companies
    2. CROs & CDMOs
    3. Academic & Research Institutes
    4. Other End Use
7. Mexico
8. Argentina
9. Chile
10. Colombia
11. Rest of LATAM